Fylde and Wyre CCG Medicines Optimisation
packings of pills and capsules of medicines on white background

Designed by Topntp26

Click each header to expand its content

Fylde Coast medicines RAG list

Application forms

Medicines commissioning policies

NameSizeHits
Actipatch for pain management 0.6 MB431
Albiglutide for type-2 diabetes mellitus 0.3 MB292
Alprostadil Cream For ED 0.3 MB327
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB437
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB262
Brimonidine For Erythema Of Rosacea 0.1 MB247
Brivaracetam for epilepsy 0.3 MB279
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB450
Certolizumab For Psoriatic Arthritis 0.1 MB218
Co-Proxamol For pain management 0.3 MB494
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB289
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB382
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB257
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB260
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB573
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB201
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB205
Denosumab for GIO 0.2 MB246
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB340
Eflornithine-cream-for-facial-hirsutism 0.2 MB267
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB205
Eslicarbazepine For Focal Seizures 0.1 MB272
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB219
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB248
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB326
Guanfacine-for-ADHD 0.3 MB215
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB229
Insulin Degludec And Liraglutide 0.2 MB246
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB255
Insulin-Degludec-for-DM 0.3 MB224
Insulin-Detemir-for-DM 0.2 MB193
Insuline-Glargine-for-T1DM 0.3 MB218
Insuline-Glargine-for-T2DM 0.3 MB213
Invicorp-injection-for-erectile-dysfunction 0.3 MB528
Ivermectin-cream-for-rosacea 0.3 MB218
JIA Policy For Adults (Version 1.0) 0.2 MB224
Lamotrigine-for-trigeminal-neuralgia 0.3 MB224
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB236
Levonorgestrel 13.5mg IUD 0.3 MB212
Lidocaine Plasters For PHN 0.2 MB273
Lidocaine-plasters-for-unlicensed-indications 0.3 MB342
Liothyronine-for-refractory-hypothyroidism 0.2 MB271
Liraglutide-for-obesity 0.3 MB275
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB491
Lisdexamfetamine-for-ADHD-update 0.3 MB272
Lurasidone-for-Schizophrenia 0.3 MB307
Magnaspartate For Hypomagnesaemia 0.3 MB1452
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB197
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB178
Midazolam-Epistatus-for-seizures 0.2 MB484
Opicapone-for-Parkinsons-disease-v2 0.5 MB271
Ospemifene for VVA 0.2 MB633
Oxycodone-Naloxone-for-Restless-legs 0.3 MB260
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB1153
Patiromer-for-hyperkalaemia 0.3 MB221
Patiromer-for-hyperkalaemia 2 0.3 MB253
Phosphodiesterase Type-5 Inhibitors 0.2 MB231
Pitolisant-for-Narcolepsyv2 0.3 MB296
Policy On Brand Inhaler Prescribing 0.3 MB837
Probiotics And VSL 0.3 MB359
Relvar Ellipta for COPD and asthma in adults 63 KB218
Rituximab-for-AIHA 0.4 MB256
Rituximab-for-ITP 0.4 MB220
Safinamide-for-Parkinsons-disease 0.3 MB255
Second-generation-LA-antipsychotics 0.3 MB257
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB233
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB187
Semaglutide for type 2 DM 0.2 MB577
Silk Garments For Eczema And Dermatitis 0.2 MB209
Simbrinza for chronic open angle glaucoma 0.1 MB228
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB289
Spironolactone For Acne 0.1 MB292
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB226
Tadalafil daily 0.3 MB442
Tapentadol for neuropathic pain in non-palliative care 0.4 MB240
Tapentadol for non-specific pain 0.2 MB248
Testosterone For Female Sexual Dysfunction 0.1 MB337
Tiotropium For Asthma 0.2 MB199
Tocilizumab SC For RA 0.1 MB185
Trelegy inhaler for COPD 0.3 MB455
Trimbow inhaler for COPD 0.4 MB352
Trimbow-inhaler-for-COPD 0.4 MB6
Ulipristal acetate for uterine fibroids 0.5 MB214
Umeclidinium For COPD 0.2 MB243
Vedolizumab For Crohn's Disease 0.2 MB207
Vesomni For Benign Prostatic Hyperplasia 0.1 MB261
Vitamins (inc Renavit) For Dialysis 0.3 MB622
Waterproof Cast Cover Policy 0.1 MB801
Xonvea for nausea and vomiting in pregnancy 0.1 MB238

Medicines guidelines, information sheets, and shared care

Further medicines guidelines are available on Lancashire Medicines Management Group’s website.

Primary care rebate schemes

Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Current Primary Care Rebate Schemes in place:

  • Clenil Modulite (Beclometasone) – commenced July 2019
  • ConvaTec – commenced January 2020
  • Dabigatran (Pradaxa) – commenced November 2020
  • Degarelix (Firmagon) – commenced September 2016
  • Edoxaban – commenced September 2018
  • Fostair NEXThaler – commenced May 2021
  • Fostair pMDI – commenced July 2021
  • Fencino (Fentanyl) – commenced April 2016
  • Lantus – commenced April 2020
  • Longtec – commenced July 2019
  • Prostap (Leuprorelin) – commenced April 2020
  • Rivaroxaban (Xarelto) – commenced October 2019
  • Sereflo – commenced July 2019
  • Toujeo (Insulin Glargine) – commenced July 2021
  • Zacco (Clobazam) – commenced March 2021
  • Zoladex (Goserelin) commenced January 2019

Fact and advice sheets

Inhaler Techniques

Inhaler technique videos are available to view online.

Last updated on 23 September 2021 at 13:57 by senior communications and engagement officer